- Title
- IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK
- Creators - without role
- Katie L. Hopkins - Public Health EnglandJacqueline Findlay - Public Health EnglandMichel Doumith - Public Health EnglandBarry Mather - Cardiff UniversityDaniele Meunier - Public Health EnglandStuart D'Arcy - Ysbyty Gwynedd Hospital NHS TrustRachel Pike - Public Health EnglandNazim Mustafa - Public Health EnglandRobin Howe - University Hospital of WalesMandy Wootton - University Hospital of WalesNeil Woodford - Public Health England
- Publication Details
- Journal of antimicrobial chemotherapy, Vol.72(7), pp.2129-2131
- Publisher
- Oxford Univ Press
- Number of pages
- 3
- Grant note
- Smith Nephew UK Ltd Rempex Pharmaceuticals Ltd BSAC Department of Health Cubist Pharmaceuticals Accelerate Diagnostics Wockhardt Ltd. Allecra Therapeutics Kalidex Pharmaceuticals Melinta Therapeutics VenatoRx Pharmaceuticals GlaxoSmithKline Services Ltd AstraZeneca UK Ltd; AstraZeneca Cepheid Food Standards Agency Amplex bioMerieux Basilea Pharmaceutica Mobidiag Merck Sharpe Dohme Corp. Norgine Pharmaceuticals Bio-Rad Laboratories; Randox Laboratories Achaogen Inc. Momentum Biosciences Ltd Becton Dickinson Diagnostics Enigma Diagnostics Henry Stewart Talks IHMA Ltd Trius Therapeutics Nordic Pharma Ltd Check-Points B.V. Rokitan Ltd Meiji Seika Pharmo Co. Ltd Roche; Roche Holding
- Identifiers
- 9920828708331
- Academic Unit
- King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
- Language
- English
- Resource Type
- Journal article
Journal article
IMI-2 carbapenemase in a clinical Klebsiella variicola isolated in the UK
Journal of antimicrobial chemotherapy, Vol.72(7), pp.2129-2131
01/07/2017
PMID: 28379381
Metrics
1 Record Views